NeuroendocrinologyArchives
Long-term survival with complete remission after irinotecan plus cisplatin therapy for metachronous liver metastasis from a gastric mixed neuroendocrine-non-neuroendocrine neoplasm: a case report
Neuroendocrinology 2 min.
Gastric mixed neuroendocrine-non-neuroendocr ine neoplasm (MiNEN), which contains exocrine and neuroendocrine components with each comprising at least 30% of the tumor, is relatively rare, accounting for about 7% of all gastric neuroendocrine neoplasms (NENs), and comprises between 0.8 and 2.5% of gastric...
SGLT2 inhibitor in a type 2 diabetes mellitus patient coexisted with central diabetes insipidus following hyperosmolar hyperglycemic state
Neuroendocrinology 3 min.
The development of central diabetes insipidus (CDI) in patients with type 2 diabetes mellitus(T2DM) complicated by hyperosmolar hyperglycemic state (HHS) is a rare occurrence [1]. HSS is most commonly observed in elderly patients with T2DM and is associated with a mortality rate 10 times higher than...
Burden of Comorbidities and Concomitant Medications and Their Associated Costs in Patients with Gastroenteropancreatic or Lung Neuroendocrine Tumors: Analysis of US Administrative Data
Neuroendocrinology 6 min.
This article is published with digital features, including a graphical , to facilitate understanding of the article. To view digital features for this article, go to 10.6084/m9.figshare.28270271. Return to the table of contents...
Deep sequencing reveals distinct microRNA-mRNA signatures that differentiate pancreatic neuroendocrine tumor from non-diseased pancreas tissue
Neuroendocrinology 7 min.
Neoplasms arising from neuroendocrine cells within pancreatic islets are known as pancreatic neuroendocrine neoplasms (PanNENs), which can be divided into two broad histopathological categories that account for both the level of differentiation and proliferation: pancreatic neuroendocrine tumors (PanNETs)...
A Randomized clinical trial evaluating the impact on survival and quality of life of 177Lutetium[Lu]-edotreotide versus everolimus in patients with neuroendocrine tumors of the lung and thymus: the LEVEL study (GETNE T-2217)
Neuroendocrinology 6 min.
Neuroendocrine tumors (NET) are rare malignancies originating from the neuroendocrine system and characterized by a well-differentiated histology [1]. The main primary tumor origin is the digestive tract, followed by the lung, which comprises approximately one-quarter to one-third of NETs with an incidence...
